| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 04/23/2009 | US20090105483 Process for the preparation of pramipexole base and/or its salts |
| 04/23/2009 | US20090105482 Urea Glucokinase Activators |
| 04/23/2009 | US20090105474 Novel anthranilic acid derivative or salt thereof |
| 04/23/2009 | US20090105316 Biphenyl Thiazole Carboxamides |
| 04/23/2009 | US20090105308 Benzoheterocylethylcarboxamide derivatives |
| 04/23/2009 | US20090105279 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV. |
| 04/23/2009 | US20090105278 Selective inhibitors of human corticosteroid syntheses |
| 04/23/2009 | US20090105257 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| 04/23/2009 | US20090105250 Compounds and compositions as protein kinase inhibitors |
| 04/23/2009 | CA2702885A1 Pharmaceutical composition for treatment of cataract |
| 04/23/2009 | CA2701792A1 Calcium receptor modulating agents |
| 04/22/2009 | EP2050467A1 Therapeutic agent for amyotrophic lateral sclerosis |
| 04/22/2009 | EP2049548A1 Fused oxazoles & thiazoles as histamine h3- receptor ligands |
| 04/22/2009 | EP2049507A2 Modulators of glucocorticoid receptor, and/or ap-1, and/or nf-kb activity and use thereof |
| 04/22/2009 | EP2049506A2 Modulators of pharmacokinetic properties of therapeutics |
| 04/22/2009 | EP2049505A2 Isoform-selective hdac inhibitors |
| 04/22/2009 | EP2048951A2 Chemical compounds |
| 04/22/2009 | EP1689391B1 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
| 04/22/2009 | EP1585518A4 Peptide deformylase inhibitors |
| 04/22/2009 | CN101415698A Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 04/22/2009 | CN101415695A Ceramide kinase modulation |
| 04/22/2009 | CN101415683A New compounds |
| 04/22/2009 | CN101412700A Crystal form and preparation of febuxostat |
| 04/22/2009 | CN101412699A Preparation of 2-(3-carboxaldehyde-4-hydroxy phenyl)-4-methyl-5-thiazole ethyl formate |
| 04/22/2009 | CN100481571C Luminescent element material and luminescent element comprising the same |
| 04/22/2009 | CN100480853C Polymeric material containing a latent acid |
| 04/21/2009 | US7521563 Hydroxamic acid derivative and medicine containing the same as active ingredient |
| 04/21/2009 | US7521466 Dipeptide phenyl ethers |
| 04/21/2009 | US7521461 2-{[4-(2-Oxo-2-{[4-(trifluoromethyl)benzyl]amino)ethyl)phenoxy]methyl}benzoic acid; peroxisome proliferator activated receptors alpha and gamma agonist; antidiabetic agents; Insulin Resistance Syndrome (IRS); cardiovascular disorders; myocardial infarction; stroke; atherosclerosis; dyslipidemia |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/16/2009 | WO2009049180A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 04/16/2009 | WO2009048544A1 Liquid pharmaceutical compositions for parenteral administration of a substituted amide |
| 04/16/2009 | WO2009047798A2 Acetamide derivatives as glucokinase activators, their process and medicinal applications |
| 04/16/2009 | WO2009047558A1 Benzothiazoles as ghrelin receptor modulators |
| 04/16/2009 | WO2009046841A2 Piperidine and piperazine derivatives for treating tumours |
| 04/16/2009 | WO2006047507A3 Phosphonate substituted kinase inhibitors |
| 04/16/2009 | US20090099019 Thiazolecarboxanilides |
| 04/16/2009 | CA2702181A1 Benzothiazoles as ghrelin receptor modulators |
| 04/16/2009 | CA2701946A1 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 04/16/2009 | CA2701519A1 Piperidine and piperazine derivatives |
| 04/16/2009 | CA2700783A1 Acetamide derivatives as glucokinase activators, their process and medicinal applications |
| 04/15/2009 | EP2048137A1 Benzamide derivatives and their use as glucokinase activating agents. |
| 04/15/2009 | EP2046766A1 Agonists of the sphingosine- 1- phosphate receptor (slp) |
| 04/15/2009 | EP2046746A2 Chemical compounds |
| 04/15/2009 | EP2046714A2 Therapeutic compounds |
| 04/15/2009 | EP1703909B1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 04/15/2009 | CN101410385A Benzothiazoles having histamine H3 receptor activity |
| 04/15/2009 | CN101410384A Compounds and methods for modulating protein trafficking |
| 04/15/2009 | CN101410375A Method for producing aromatic compound |
| 04/15/2009 | CN101407503A 2-(4-aryl thiazole-2-yl)-3-alkyloxy acrylonitrile compounds and uses thereof |
| 04/15/2009 | CN101407502A N-(t-butoxy carbonyl ) timonacic compounds, and preparation and use thereof |
| 04/15/2009 | CN101407344A Process for treating waste water of rubber vulcanization accelerator NS production |
| 04/14/2009 | US7517998 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus |
| 04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
| 04/14/2009 | US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 04/14/2009 | US7517879 Pyrrolidine derivatives as factor Xa inhibitors |
| 04/14/2009 | US7517535 Agonists and antagonists of nicotinergic acetylcholine receptors of insects like fleas, lice and flies, on humans or animals; chloronicotinyl insecticides such as imidaclopridas veterinary medicine; collars; tags |
| 04/14/2009 | US7517368 Indolylthiazoliumazo dyes-containing colorants for keratin fibers |
| 04/09/2009 | WO2009044250A1 New compounds as adenosine a1 receptor antagonists |
| 04/09/2009 | WO2009026227A3 Highly selective sigma receptor ligands |
| 04/09/2009 | WO2009007022A3 Iminooxazole and iminothiazole compounds as pesticides |
| 04/09/2009 | WO2006069217A3 Small molecule cyclin d1 ablative agents |
| 04/09/2009 | US20090093530 (2R)-2-[4-Sulfonyl) Aminophenyl] Propanamides and Pharmaceutical Compositions Containing Them |
| 04/09/2009 | US20090093529 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
| 04/09/2009 | US20090093485 Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases |
| 04/09/2009 | US20090091252 Binaphthyl compound and organic light emitting element using the same |
| 04/09/2009 | US20090091234 Room temperature molten salt and display element |
| 04/09/2009 | CA2701115A1 N-hydroxy-naphthalene dicarboxamide and n-hydroxy-biphenyl-dicarboxamide compounds as histone deacetylase inhibitors |
| 04/09/2009 | CA2700526A1 New compounds as adenosine a1 receptor antagonists |
| 04/09/2009 | CA2698928A1 Compounds and methods for treating zinc matrix metalloprotease dependent diseases |
| 04/08/2009 | EP2044042A2 Polymorphic forms of { 2-methyl-4- [4-methyl-2- (trifluoromethylphenyl) thiazol-5-methylthiol phenoxy}-acetic acid |
| 04/08/2009 | EP2043993A2 Cyclopentane derivatives as antiglaucoma agents |
| 04/08/2009 | EP1877364B1 Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/08/2009 | EP1786792B1 Thiazole derivatives having vap-1 inhibitory activity |
| 04/08/2009 | EP1718667A4 Heterocyclic self-immolative linkers and conjugates |
| 04/08/2009 | CN101405884A Method for preparing doped organic semiconductor materials and formulation utilized therein |
| 04/08/2009 | CN101405278A Novel heterocyclic NF-kB inhibitors |
| 04/08/2009 | CN101405266A Piperazines and piperidines as mGlur5 potentiators |
| 04/08/2009 | CN101404999A Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones |
| 04/08/2009 | CN101402615A Fine purification method for rubber vulcanization accelerant 2-mercaptobenzothiazole (M) |
| 04/08/2009 | CN101402606A Nitrogen heterocyclic ring substituted arylpropenone compounds, preparation method and application thereof |
| 04/08/2009 | CN100475810C Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists |
| 04/08/2009 | CN100475799C Merocyanine derivatives for cosmetic use |
| 04/08/2009 | CN100475797C Method of obtaining 2-mercaptobenzothiazole |
| 04/08/2009 | CN100475796C Thiazole derivatives as cannabinoid receptor modulators |
| 04/08/2009 | CN100475789C Process for the preparation of thioalkylamine derivatives |
| 04/08/2009 | CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/07/2009 | US7514566 Thiazole compounds and methods of use |
| 04/07/2009 | US7514565 3,5-Difluoropyridines |
| 04/07/2009 | US7514557 Hepatitis C; preparing 8-bromo-7-alkoxyquinolines 2-substituted with a hetercyclic ring having an amine, carbamate, amine or urea group an 4-substituted with a 3-prolineoxy- group or derivative; intermediates |
| 04/07/2009 | US7514457 Substituted aryloxymethyl bicyclicmethyl acetamide compounds |
| 04/07/2009 | US7514439 Oxime derivative and preparations thereof |
| 04/07/2009 | US7514431 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 04/07/2009 | CA2276278C Amine compounds, their production and use |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/02/2009 | WO2009041790A1 Novel 2,4,5-trisubtituted-1,3-thiazole derivatives and pharmaceutically acceptable salt thereof, method for preparation, therapeutic agent for inflammatory disease induced by spc activity containing 2,4,5- trisubstituted-1,3-thiazole derivatives as an effective ingredient |
| 04/02/2009 | WO2009041447A1 5-membered heterocyclic compound |
| 04/02/2009 | WO2009040507A1 Substituted benamidines as antibacterial agents |
| 04/02/2009 | WO2009040331A2 Amidine, thiourea and guanidine derivatives of 2-aminobenzothiazoles and aminobenzothiazines for their use as pharmacological agents for the treatment of neurodegenerative pathologies |
| 04/02/2009 | WO2009040288A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |